These analysts follow the development of Calliditas Therapeutics on a regular basis.
Bryan, Garnier & Co
Ingrid Gafanhão
Carnegie Investment Bank AB
Erik Hultgård
Citi
Yigal Nochomovitz
Jefferies
Maury Raycroft
Kempen
Suzanne van Voorthuizen
Kepler Cheuvreux
Jon Berggren
LifeSci Capital
Rami Katkhuda
Pareto Securities
Dan Akschuti
Stifel
Annabel Samimy
Guggenheim
Vamil Divan
SEB
Christopher W. Uhde